Format
Sort by
Items per page

Send to

Choose Destination

See syndrome syndrome in the Gene database

Search results

Items: 1 to 20 of 4516

1.

Erdheim-Chester disease with unusual clinicopathological features complicated by DRESS syndrome, disseminated Cytomegalovirus infection and hemophagocytic lymphohistiocytosis.

Gaspar BL, Vasishta RK, Das R, Bhalla A.

APMIS. 2017 Apr 18. doi: 10.1111/apm.12694. [Epub ahead of print] No abstract available.

PMID:
28418177
2.

[Epicutaneous patch testing in delayed drug hypersensitivity reactions induced by antiepileptic drugs].

Ben Mahmoud L, Bahloul N, Ghozzi H, Kammoun B, Hakim A, Sahnoun Z, Kammoun S, Zeghal K.

Therapie. 2017 Mar 25. pii: S0040-5957(17)30055-0. doi: 10.1016/j.therap.2017.01.011. [Epub ahead of print] French.

PMID:
28416298
3.

Cutaneous Allergic Drug Reactions: Update on Pathophysiology, Diagnostic Procedures and Differential Diagnostic.

Balakirski G, Merk HF.

Cutan Ocul Toxicol. 2017 Apr 17:1-37. doi: 10.1080/15569527.2017.1319379. [Epub ahead of print]

PMID:
28412864
4.

A histological study of fulminant type 1 diabetes mellitus related to human cytomegalovirus reactivation.

Yoneda S, Imagawa A, Fukui K, Uno S, Kozawa J, Sakai M, Yumioka T, Iwahashi H, Shimomura I.

J Clin Endocrinol Metab. 2017 Apr 10. doi: 10.1210/jc.2016-4029. [Epub ahead of print]

PMID:
28398495
5.

Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome in Children: A Case Report.

Mattoussi N, Ben Mansour A, Essadam L, Guedri R, Fitouri Z, Ben Becher S.

J Investig Allergol Clin Immunol. 2017;27(2):144-146. doi: 10.18176/jiaci.0140. No abstract available.

6.

Patch testing and cross sensitivity study of adverse cutaneous drug reactions due to anticonvulsants: A preliminary report.

Shiny TN, Mahajan VK, Mehta KS, Chauhan PS, Rawat R, Sharma R.

World J Methodol. 2017 Mar 26;7(1):25-32. doi: 10.5662/wjm.v7.i1.25. eCollection 2017 Mar 26.

7.

Drug Reaction with Eosinophilia and Systemic Symptom Syndrome Induced by Lamotrigine.

Han SH, Hur MS, Youn HJ, Roh NK, Lee YW, Choe YB, Ahn KJ.

Ann Dermatol. 2017 Apr;29(2):206-209. doi: 10.5021/ad.2017.29.2.206. Epub 2017 Mar 24.

8.

Lipoprotein-X in cholestatic patients causes xanthomas and promotes foam cell formation in human macrophages.

Suzuki L, Hirayama S, Fukui M, Sasaki M, Hiroi S, Ayaori M, Terai S, Tozuka M, Watada H, Miida T.

J Clin Lipidol. 2017 Jan - Feb;11(1):110-118. doi: 10.1016/j.jacl.2016.10.013. Epub 2016 Nov 5.

PMID:
28391876
9.

Influence of genetic and non-genetic factors on phenytoin-induced severe cutaneous adverse drug reactions.

Yampayon K, Sukasem C, Limwongse C, Chinvarun Y, Tempark T, Rerkpattanapipat T, Kijsanayotin P.

Eur J Clin Pharmacol. 2017 Apr 8. doi: 10.1007/s00228-017-2250-2. [Epub ahead of print]

PMID:
28391407
10.

Physiotherapy and Speech and Language therapy intervention for chronic cough.

Birring SS, Floyd S, Reilly CC, Siu Pan Cho P.

Pulm Pharmacol Ther. 2017 Apr 4. pii: S1094-5539(17)30011-1. doi: 10.1016/j.pupt.2017.04.001. [Epub ahead of print] Review.

PMID:
28389257
11.

Non-immediate Cutaneous Reactions to Beta-Lactams: Approach to Diagnosis.

Romano A, Valluzzi RL, Caruso C, Maggioletti M, Gaeta F.

Curr Allergy Asthma Rep. 2017 Apr;17(4):23. doi: 10.1007/s11882-017-0691-4. Review.

PMID:
28382604
12.

Association of the HLA-B*53:01 Allele With Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome During Treatment of HIV Infection With Raltegravir.

Thomas M, Hopkins C, Duffy E, Lee D, Loulergue P, Ripamonti D, Ostrov DA, Phillips E.

Clin Infect Dis. 2017 May 1;64(9):1198-1203. doi: 10.1093/cid/cix096.

PMID:
28369189
13.

Severe Cutaneous Adverse Drug Reactions in Pediatric Patients: A Multicenter Study.

Dibek Misirlioglu E, Guvenir H, Bahceci S, Haktanir Abul M, Can D, Usta Guc BE, Erkoco─člu M, Toyran M, Nacaroglu HT, Civelek E, Buyuktiryaki B, Ginis T, Orhan F, Kocabas CN.

J Allergy Clin Immunol Pract. 2017 Mar 25. pii: S2213-2198(17)30101-0. doi: 10.1016/j.jaip.2017.02.013. [Epub ahead of print]

PMID:
28351788
14.

Lamotrigine-related pseudolymphoma presenting as cervical lymphadenopathy.

Mulroy E, Walker E.

Epilepsy Behav Case Rep. 2017 Jan 18;7:40-41. doi: 10.1016/j.ebcr.2016.12.004. eCollection 2017.

15.

Novel interferon-╬│ enzyme-linked immunoSpot assay using activated cells for identifying hypersensitivity-inducing drug culprits.

Kato K, Kawase A, Azukizawa H, Hanafusa T, Nakagawa Y, Murota H, Sakaguchi S, Asada H, Katayama I.

J Dermatol Sci. 2017 Mar 14. pii: S0923-1811(16)31063-5. doi: 10.1016/j.jdermsci.2017.03.007. [Epub ahead of print]

PMID:
28330775
16.

Multiple Drug Hypersensitivity.

Pichler WJ, Srinoulprasert Y, Yun J, Hausmann O.

Int Arch Allergy Immunol. 2017 Mar 18;172(3):129-138. doi: 10.1159/000458725. [Epub ahead of print]

17.

Adverse drug reactions triggered by the common HLA-B*57:01 variant: a molecular docking study.

Van Den Driessche G, Fourches D.

J Cheminform. 2017 Mar 4;9:13. doi: 10.1186/s13321-017-0202-6. eCollection 2017.

18.

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Standard Reporting and Evaluation Guidelines: Results of a National Institutes of Health Working Group.

Maverakis E, Wang EA, Shinkai K, Mahasirimongkol S, Margolis DJ, Avigan M, Chung WH, Goldman J, La Grenade L, Pirmohamed M, Shear NH, Tassaeeyakul W, Hoetzenecker W, Klaewsongkram J, Rerkpattanapipat T, Manuyakorn W, Yasuda SU, Sharon VR, Sukhov A, Micheletti R, Struewing J, French LE, Cheng MY.

JAMA Dermatol. 2017 Mar 15. doi: 10.1001/jamadermatol.2017.0160. [Epub ahead of print]

PMID:
28296986
19.

Difficult clinical management of antituberculosis DRESS syndrome complicated by MRSA infection: A case report.

Wang L, Li LF.

Medicine (Baltimore). 2017 Mar;96(11):e6346. doi: 10.1097/MD.0000000000006346.

20.

Pharmacogenomic advances in the prediction and prevention of cutaneous idiosyncratic drug reactions.

Pan RY, Dao RL, Hung SI, Chung WH.

Clin Pharmacol Ther. 2017 Mar 15. doi: 10.1002/cpt.683. [Epub ahead of print]

PMID:
28295240

Supplemental Content

Loading ...
Support Center